Evidence map›Paper›PMID 36279902›Full record

SynthesisInternational journal of cancer2023

Postdiagnosis dietary factors, supplement use and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.

Nerea Becerra-Tomás, Katia Balducci, Leila Abar, Dagfinn Aune, Margarita Cariolou, Darren C Greenwood, Georgios Markozannes, Neesha Nanu, Rita Vieira, Edward L Giovannucci and 18 more

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in International journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Effects of a Physical Activity mHealth Intervention (Fit2Thrive) on WCRF/AICR Cancer Prevention Recommendations among Breast Cancer Survivors: A Secondary Data Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Trial
  9. Review
  10. Review
  11. Article
  12. Article
  13. Landscape analysis of oncology nutrition research among patients being treated for cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Nerea Becerra-TomásDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Katia BalducciDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Leila AbarDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Dagfinn AuneDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Margarita CariolouDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Darren C GreenwoodLeeds Institute for Data Analytics, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Georgios MarkozannesDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Neesha NanuDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Rita VieiraDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Edward L GiovannucciDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Marc J GunterNutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
Alan A JacksonFaculty of Medicine, School of Human Development and Health, University of Southampton, Southampton, UK.
Ellen KampmanDivision of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.
Vivien LundWorld Cancer Research Fund International, London, UK.
Kate AllenWorld Cancer Research Fund International, London, UK.
Nigel T BrocktonAmerican Institute for Cancer Research, Arlington, Virginia, USA.
Helen CrokerWorld Cancer Research Fund International, London, UK.
Daphne KatsikiotiWorld Cancer Research Fund International, London, UK.
Deirdre McGinley-GieserAmerican Institute for Cancer Research, Arlington, Virginia, USA.
Panagiota MitrouWorld Cancer Research Fund International, London, UK.
Martin WisemanWorld Cancer Research Fund International, London, UK.
Amanda J CrossDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Steven K ClintonDivision of Medical Oncology, The Department of Internal Medicine, College of Medicine and Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Anne McTiernanDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Teresa NoratDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Konstantinos K TsilidisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.ORCID 0000-0002-8452-8472
Doris S M ChanDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.ORCID 0000-0002-0198-1897

Funding

Cancer Research UK 25004World Health Organization 001
6 · The paper itself

Abstract

Little is known about how diet might influence breast cancer prognosis. The current systematic reviews and meta-analyses summarise the evidence on postdiagnosis dietary factors and breast cancer outcomes from randomised controlled trials and longitudinal observational studies. PubMed and Embase were searched through 31st October 2021. Random-effects linear dose-response meta-analysis was conducted when at least three studies with sufficient information were available. The quality of the evidence was evaluated by an independent Expert Panel. We identified 108 publications. No meta-analysis was conducted for dietary patterns, vegetables, wholegrains, fish, meat, and supplements due to few studies, often with insufficient data. Meta-analysis was only possible for all-cause mortality with dairy, isoflavone, carbohydrate, dietary fibre, alcohol intake and serum 25-hydroxyvitamin D (25(OH)D), and for breast cancer-specific mortality with fruit, dairy, carbohydrate, protein, dietary fat, fibre, alcohol intake and serum 25(OH)D. The results, with few exceptions, were generally null. There was limited-suggestive evidence that predefined dietary patterns may reduce the risk of all-cause and other causes of death; that isoflavone intake reduces the risk of all-cause mortality (relative risk (RR) per 2 mg/day: 0.96, 95% confidence interval (CI): 0.92-1.02), breast cancer-specific mortality (RR for high vs low: 0.83, 95% CI: 0.64-1.07), and recurrence (RR for high vs low: 0.75, 95% CI: 0.61-0.92); that dietary fibre intake decreases all-cause mortality (RR per 10 g/day: 0.87, 95% CI: 0.80-0.94); and that serum 25(OH)D is inversely associated with all-cause and breast cancer-specific mortality (RR per 10 nmol/L: 0.93, 95% CI: 0.89-0.97 and 0.94, 95% CI: 0.90-0.99, respectively). The remaining associations were graded as limited-no conclusion.

Indexed as

Dietary SupplementsNeoplasmsAnimalsDietDietary FatsVegetablesDietary Fatsbreast cancer survivaldietevidence gradingfoodsystematic review

Identifiers

PMID36279902
PMCPMC10092903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.